Finance

Lists
Outlook: 29.0% bullish·3.2% bearish
Go to analysis
KMB:NASDAQ
Kimberly-Clark Corp
$110.15
-1.93%
(-2.17) 1D
$110.00
-0.14% (-0.15)
After hours
Closed: Oct 23, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KMB...
Open
$111.46
High
$112.05
Low
$108.92
Mkt. cap
36.63B
Avg. vol.
4.70M
Volume
5.60M
Dividend
4.65%
Quarterly dividend
$1.28
Ex-dividend date
Sep 4, 2026
P/E ratio
18.77
52-wk high
$123.09
52-wk low
$92.42
EPS
$5.87
Beta
0.25
Shares outstanding
332.58M
No. of employees
36K
Open
$111.46
High
$112.05
Low
$108.92
Mkt. cap
36.63B
Avg. vol.
4.70M
Volume
5.60M
Dividend
4.65%
Quarterly dividend
$1.28
Ex-dividend date
Sep 4, 2026
P/E ratio
18.77
52-wk high
$123.09
52-wk low
$92.42
EPS
$5.87
Beta
0.25
Shares outstanding
332.58M
No. of employees
36K
News stories
From web sources and news partners
Profile
Kimberly-Clark Corporation is an American multinational consumer goods and personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes. Founded in Neenah, Wisconsin, in 1872 and based in the Las Colinas section of Irving, Texas, since 1985, the company operated its own paper mills around the world for decades, but closed the last of those in 2012. With recent annual revenues topping $18 billion per year, Kimberly-Clark is regularly listed among the Fortune 500. As of March 2020, the company had approximately 40,000 employees. Wikipedia
About Kimberly-Clark Corp
CEOMichael D. Hsu
Employees36K
Founded1872
HeadquartersIrving, Texas, United States
SectorHousehold goods
Websitekimberly-clark.com
Analyst ratings
Based on 13 analysts giving stock ratings to KMB in the past 3 months
Buy
Buy
5
Hold
7
Sell
1
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for KMB in the last 3 months.
Highest
Current $110.15
$162.00 (+47.07%)
Average
$113.23 (+2.80%)
Lowest
$90.00 (-18.29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Susan Anderson
Canaccord Genuity
Hold
Initiated
$105.00
-4.7%
10/23/2026
Anna Lizzul
Bank of America Securities
Buy
Maintained
$120.00
+8.9%
10/20/2026
Christopher Carey
Wells Fargo
Hold
Reiterated
$100.00
-9.2%
10/16/2026
Peter Grom
UBS
Hold
Reiterated
$106.00
-3.8%
10/15/2026
Lauren Lieberman
Barclays
Hold
Maintained
$106.00
-3.8%
10/15/2026
Unknown Analyst
Citi
Sell
Maintained
$90.00
-18.3%
10/14/2026
Robert Moskow
TD Cowen
Hold
Maintained
$97.00
-11.9%
10/13/2026
Nik Modi
RBC Capital
Buy
Maintained
$162.00
+47.1%
10/06/2026
Michael Lavery
Piper Sandler
Buy
Maintained
$118.00
+7.1%
09/11/2026
Taylor Conrad
Argus Research
Buy
Maintained
$120.00
+8.9%
08/21/2026
Javier Escalante
Evercore ISI
Hold
Maintained
$115.00
+4.4%
08/05/2026
Stephen Powers
Deutsche Bank
Hold
Reiterated
$112.00
+1.7%
08/05/2026
Georgy Vashchenko
Freedom Capital Markets
Buy
Upgraded
$121.00
+9.9%
08/04/2026
Peter Galbo
Bank of America Securities
Buy
Reiterated
$120.00
+8.9%
05/14/2026
Andy Sim
DBS
Hold
Maintained
$111.00
+0.8%
04/28/2026
Filippo Falorni
Citi
Sell
Maintained
$90.00
-18.3%
04/15/2026
Unknown Analyst
Rothschild & Co Redburn
Buy
Maintained
$142.00
+28.9%
02/13/2026
Next call in 12 days
Thu, Nov 5, 3:00 PM
Fiscal period
Q3 2026
- / $1.64
Revenue / Est. (USD)
- / 4.12B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.15B
4.08B
4.16B
4.19B
Cost of goods sold
2.62B
2.57B
2.59B
2.56B
Cost of revenue
2.62B
2.57B
2.59B
2.56B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
827.00M
968.00M
900.00M
862.00M
Operating expense
834.00M
972.00M
758.00M
829.00M
Total operating expenses
3.46B
3.54B
3.34B
3.39B
Operating income
693.00M
537.00M
818.00M
796.00M
Other non operating income
-16.00M
49.00M
-15.00M
-12.00M
EBT including unusual items
592.00M
495.00M
738.00M
627.00M
EBT excluding unusual items
654.00M
585.00M
800.00M
790.00M
Income tax expense
248.00M
104.00M
164.00M
217.00M
Effective tax rate
41.89%
21.01%
22.22%
34.61%
Other operating expenses
7.00M
4.00M
-142.00M
-33.00M
Net income
446.00M
499.00M
665.00M
345.00M
Net profit margin
10.75%
12.23%
15.97%
8.24%
Earnings per share
1.82
1.86
1.97
2.12
Interest and investment income
6.00M
6.00M
5.00M
4.00M
Interest expense
-65.00M
-60.00M
-58.00M
-53.00M
Net interest expenses
-59.00M
-54.00M
-53.00M
-49.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
869.00M
601.00M
980.00M
994.00M
Gain or loss from assets sale
6.00M
-3.00M
-19.00M
12.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps